Table 2.
Findings from interventional and angiographic evaluations.
| n = 126 | ||
|---|---|---|
| Multivessel disease* | 66(52.4) | |
| Target lesion location | ||
| Left main coronary artery | 1(0.8) | |
| Left anterior descending coronary artery | 69(54.8) | |
| Left circumflex coronary artery | 33(26.2) | |
| Right coronary artery | 23(18.3) | |
| Bifurcation | 23(18.3) | |
| Ostial lesion | 11(8.7) | |
| Total occlusion | 22(17.5) | |
| Lesion length (mm) | 7.3 (5.5, 12.1) | |
| Predilatation | 120(95.2) | |
| Scoring/cutting balloon | 104(82.5) | |
| Noncompliant balloon | 117(92.9) | |
| Minimal lumen diameter (mm) | Pre- PCI | 1.2 (0.8, 1.5) |
| Post- PCI | 2.8 (2.6, 3.2) | |
| Reference vessel diameter (mm) | 2.68 ± 0.73 | |
| Diameter stenosis (%) | Pre- PCI | 63.9 (51.1, 72.8) |
| Post- PCI | 12.2 (6.9, 20.0) | |
| Target lesion calcification | Moderate | 19(15.1) |
| Severe | 26(20.6) | |
| Radiolucent mass | 12(9.5) | |
| SER treatment | ||
| New DES implantation | 76(60.3) | |
| DCB | 50(39.7) | |
Values are n (%), mean ± SD or median (first quartile, third quartile).
PCI percutaneous coronary intervention, SER stent edge restenosis, DCB drug-coated balloon, DES drug-eluting stents.
*Characterized by a diameter stenosis exceeding 50% in two or more major coronary epicardial arteries.